Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2577

1.

[Use of herbal medicine for cancer treatment-related toxicities].

Samuels N, Morag O, Maimon Y.

Harefuah. 2015 Jan;154(1):43-6, 67. Hebrew.

PMID:
25796675
2.

Sub-staging colorectal cancers and adjuvant treatments.

Lorenzon L, Balducci G, Ferri M.

J Am Coll Surg. 2015 Mar;220(3):379-81. doi: 10.1016/j.jamcollsurg.2014.12.005. No abstract available.

PMID:
25700909
3.

Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer.

Simpson AL, Leal JN, Pugalenthi A, Allen PJ, DeMatteo RP, Fong Y, Gönen M, Jarnagin WR, Kingham TP, Miga MI, Shia J, Weiser MR, D'Angelica MI.

J Am Coll Surg. 2015 Mar;220(3):271-80. doi: 10.1016/j.jamcollsurg.2014.12.008. Epub 2014 Dec 13.

PMID:
25617913
4.

Adjuvant chemoradiation plus intraoperative radiotherapy versus adjuvant chemoradiation alone in patients with locally advanced rectal cancer.

Zhang Q, Tey J, Yang Z, Li P, Peng L, Fu S, Huang G, Xiong F, Lu JJ.

Am J Clin Oncol. 2015 Feb;38(1):11-6. doi: 10.1097/COC.0b013e318287bb8d.

PMID:
25616201
5.

Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.

Breugom AJ, Swets M, Bosset JF, Collette L, Sainato A, Cionini L, Glynne-Jones R, Counsell N, Bastiaannet E, van den Broek CB, Liefers GJ, Putter H, van de Velde CJ.

Lancet Oncol. 2015 Feb;16(2):200-7. doi: 10.1016/S1470-2045(14)71199-4. Epub 2015 Jan 12. Review.

PMID:
25589192
6.

Systematic review with network meta-analysis: adjuvant chemotherapy for resected colorectal liver metastases.

Zhu GQ, You J, Shi KQ, He SY, Wang LR, Chen YP, Braddock M, Zheng MH.

Medicine (Baltimore). 2015 Jan;94(1):e379. doi: 10.1097/MD.0000000000000379. Review.

PMID:
25569666
7.

[Blindness and symmetrical neurological deficit in a patient with colon cancer receiving adjuvant chemotherapy: is it always cancer?].

Leshem Y, Fennig S, Talianski E, Greenberg G, Wolf I.

Harefuah. 2014 Nov;153(11):650-1, 687. Hebrew.

PMID:
25563024
8.

[Combined treatment of patients with locally advanced rectal cancer].

Berdov BA, Erygin DV, Nevol'skikh AA, Titova LN, Zamulaeva IA, Kondrashova LM.

Vopr Onkol. 2014;60(4):497-503. Russian.

PMID:
25552072
9.

[Immediate and late follow-up results of surgical and combined treatment of patients with colonic cancer of various localization in right half of the colon].

Miasoedov SD, Koshel' KV, Miasoedov DV, Gordiĭchuk PI, Tersenov IaA, Kukhar IV, Bogdanova SI.

Klin Khir. 2014 Sep;(9):14-8. Russian.

PMID:
25509426
10.

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.

Schmoll HJ, Twelves C, Sun W, O'Connell MJ, Cartwright T, McKenna E, Saif M, Lee S, Yothers G, Haller D.

Lancet Oncol. 2014 Dec;15(13):1481-92. doi: 10.1016/S1470-2045(14)70486-3. Epub 2014 Nov 12.

PMID:
25456367
11.

How can we improve adjuvant chemotherapy for colon cancer?

Boku N.

Lancet Oncol. 2014 Dec;15(13):1413-5. doi: 10.1016/S1470-2045(14)71034-4. Epub 2014 Nov 12. No abstract available.

PMID:
25456355
12.

Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial.

Gao YH, Lin JZ, An X, Luo JL, Cai MY, Cai PQ, Kong LH, Liu GC, Tang JH, Chen G, Pan ZZ, Ding PR.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1153-60. doi: 10.1016/j.ijrobp.2014.07.021. Epub 2014 Oct 13.

PMID:
25442042
13.

Dilemma of stage II colon cancer and decision making for adjuvant chemotherapy.

Fang SH, Efron JE, Berho ME, Wexner SD.

J Am Coll Surg. 2014 Nov;219(5):1056-69. doi: 10.1016/j.jamcollsurg.2014.09.010. Epub 2014 Sep 19. Review. No abstract available.

PMID:
25440029
14.

Efficacy of perioperative chemotherapy in patients with colorectal cancer undergoing hepatectomy for resectable synchronous liver metastasis.

Nakanishi M, Kuriu Y, Murayama Y, Konishi H, Komatsu S, Shiozaki A, Ikoma H, Kubota T, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Otsuji E.

Hepatogastroenterology. 2014 Sep;61(134):1582-7.

PMID:
25436346
15.

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

Ng K, Meyerhardt JA, Chan AT, Sato K, Chan JA, Niedzwiecki D, Saltz LB, Mayer RJ, Benson AB 3rd, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Venook AP, Ogino S, Giovannucci EL, Fuchs CS.

J Natl Cancer Inst. 2014 Nov 27;107(1):345. doi: 10.1093/jnci/dju345. Print 2015 Jan.

PMID:
25432409
16.

The evolution of liver-directed treatments for hepatic colorectal metastases.

Park J, Chen YJ, Lu WP, Fong Y.

Oncology (Williston Park). 2014 Nov;28(11):991-1003.

17.

DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147).

Lee AM, Shi Q, Pavey E, Alberts SR, Sargent DJ, Sinicrope FA, Berenberg JL, Goldberg RM, Diasio RB.

J Natl Cancer Inst. 2014 Nov 7;106(12). pii: dju298. doi: 10.1093/jnci/dju298. Print 2014 Dec.

PMID:
25381393
18.

Adjuvant chemotherapy for t1 node-positive colon cancers provides significant survival benefit.

Ganapathi AM, Speicher PJ, Englum BR, Castleberry AW, Migaly J, Hsu DS, Mantyh CR.

Dis Colon Rectum. 2014 Dec;57(12):1341-8. doi: 10.1097/DCR.0000000000000245.

19.

Safety and efficacy of radiofrequency ablation with aflibercept and FOLFIRI in a patient with metastatic colorectal cancer.

Agarwal A, Daly KP, Butler-Bowen H, Saif MW.

Anticancer Res. 2014 Nov;34(11):6775-8.

PMID:
25368290
20.

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.

Kumar A, Kennecke HF, Renouf DJ, Lim HJ, Gill S, Woods R, Speers C, Cheung WY.

Cancer. 2015 Feb 15;121(4):527-34. doi: 10.1002/cncr.29072. Epub 2014 Oct 20.

PMID:
25332117
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk